SAREPTA THERAPEUTICS INC's ticker is and the CUSIP is 803607AB6. A total of 42 filers reported holding SAREPTA THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $18,432,675 | +3.9% | 10,370,000 | 0.0% | 1.98% | +2.8% |
| Q2 2023 | $17,732,700 | -6.8% | 10,370,000 | -28.5% | 1.93% | +260.2% |
| Q1 2021 | $19,031,000 | -78.4% | 14,500,000 | -78.0% | 0.54% | -88.0% |
| Q3 2019 | $88,275,000 | -29.2% | 66,000,000 | +17.9% | 4.47% | -13.9% |
| Q2 2019 | $124,705,000 | +7.8% | 56,000,000 | -12.5% | 5.19% | +21.8% |
| Q1 2019 | $115,720,000 | – | 64,000,000 | – | 4.26% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DeepCurrents Investment Group LLC | 92,999,000 | $138,298,000 | 4.13% |
| WOLVERINE ASSET MANAGEMENT LLC | 84,505,000 | $125,210,000 | 1.08% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 20,000,000 | $29,789,000 | 0.79% |
| Verition Fund Management LLC | 27,047,000 | $40,063,000 | 0.35% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 7,970,000 | $11,789,000 | 0.22% |
| Baker Brothers Advisors | 29,174,000 | $43,167,000 | 0.19% |
| Calamos Advisors LLC | 23,631,000 | $35,035,000 | 0.15% |
| RWC Asset Management LLP | 2,900,000 | $4,300,000 | 0.13% |
| Aequim Alternative Investments LP | 1,957,000 | $2,899,000 | 0.11% |
| PALISADE CAPITAL MANAGEMENT, LP | 3,148,000 | $4,666,000 | 0.10% |